Skip to content

Clinical trials

Completed Phase 2 Hereditary Sensory and Autonomic Neuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 2 Status: Completed Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20102
20113
20122
20171
20182
20191
20202
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
EMD Serono Research & Development Institute, Inc.2
Incyte Corporation2
Pfizer2
Aadi Bioscience, Inc.1
Actuate Therapeutics Inc.1
Alejandra Guillermina Miranda Diaz1
AstraZeneca1
Buddhist Tzu Chi General Hospital1
Grupo Espanol Multidisciplinario del Cancer Digestivo1
Jinling Hospital, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies19
Colorectal Neoplasms2
Neoplasm Metastasis2
Neoplasms2
Alzheimer Disease1
Anemia, Hemolytic, Autoimmune1
Ataxia Telangiectasia1
Brain Injuries, Traumatic1
Breast Neoplasms1
Bronchial Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.